ClinicalTrials.Veeva

Menu

Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection

Clalit Health Services logo

Clalit Health Services

Status and phase

Withdrawn
Phase 4

Conditions

Urinary Tract Infection

Treatments

Drug: Hyaluronic Acid

Study type

Interventional

Funder types

Other

Identifiers

NCT02034890
RMC-7350

Details and patient eligibility

About

Prospective trial which includes instillation of intravesical hyaluronic acid in an attempt to reduce the incidence of urinary tract infections in patients after orthotopic neobladder reconstruction.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients undergoing radical cystectomy and orthotopic neobladder reconstruction

Exclusion criteria

  • patients <18 years and unwilling to participate in this study

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 2 patient groups

hyaluronic acid
Experimental group
Description:
intravesical instillation of 40 mg of hyaluronic acid at 6 specific time points: 1,2,3 and 4 weeks postoperatively 2 and 3 months postoperatively
Treatment:
Drug: Hyaluronic Acid
retrospective control patients
No Intervention group
Description:
retrospective control patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems